Jörg Schmidt

ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland.

Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.

BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector.

numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany.

Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany.

Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland.

LifeCare Partners GmbH is an independent investment firm which provides private equity and mezzanine financing to life science and healthcare companies. The firm is headquartered in Basel, Switzerland.

leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany.

Diamedcare AG provides financing services. The private company is based in Basel, Switzerland. The Swiss company was founded in 2016 by Gerhard Ries. Gerhard Ries has been the CEO since 2016.

Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany.

Part of Geratherm Medical AG, apoplex medical technologies GmbH is a health tech provider based in Pirmasens, Germany. The German company uses advanced technology to develop software-supported health services for stroke diagnostics worldwide. The company's goal is to make future-oriented cardiological diagnostics efficient and accessible to everyone. The company has been providing validated solutions since 2006 and have 250 satisfied customers. The company's product, SRA®+ stroke risk analysis, is a proven algorithm that analyzes EKG data fully automatically for cardiac arrhythmia atrial fibrillation. The subsequent cardiological diagnosis of the results rounds off the smart diagnostic solution.

Precision OS Technology provides orthopedic VR software. It offers virtual reality software for tiered surgeon education and critical surgical metrics with haptic feedback. The company was founded y P. Goel, Colin O'Connor and Roberto Oliveira in 2017 and is headquartered in Vancouver, Canada.

SkyCell AG manufactures and rents air cargo containers. It offers containers for expensive and temperature sensitive goods in the pharmaceutical industry. The company was founded by Nico Ros and Richard Ettl in 2013 and is headquartered in Zurich, Switzerland.

DiaMedCare GmbH provides business consulting services. The private company is based in Munich, Germany. The German company was founded in 2016 by Gerhard Ries. The CEO is Dimitrios Dimitrakopoulos.

Leopard Capital 1 Ltd. is a British real estate company that was founded in 2016. The private company is based in Salisbury, UK. The company engages in buying and selling of real estate properties.

Leopard Capital 3 Ltd. is a British real estate company that was founded in 2017. The private company is based in Salisbury, UK. The company engages in buying and selling of real estate properties.

Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany.

Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland.

LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany.